HIGHLIGHTS
- who: Long Liang from the Riphah International University, Tangdu Hospital, China have published the Article: Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study, in the Journal: (JOURNAL)
- what: The authors considered that the main reason for this phenomenon was that the proportion of patients with well- and moderately differentiated pathological types was low, and chemotherapy can have a better positive therapeutic effect for the above pathological types, while it may have a negative effect on poorly differentiated or undifferentiated pathological types.
- how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.